Author

Nadia Naldi

Observed names: N Naldi, N. Naldi

Institutions: University of Parma, Ospedale di Parma

Observed institutions: Marche Polytechnic University, University of Parma, University of Ferrara, University of Pavia, Maastricht University Medical Centre, Ospedale Santa Chiara, Azienda Ospedaliera di Perugia, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Santa Maria Nuova Hospital, Azienda Ospedaliero-Universitaria delle Marche, Ospedale di Parma, Ospedaliera di Piacenza, Istituti Ospitalieri di Cremona

OpenAlex ID: A5024486104

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer

2008 · Antonino Musolino, Nadia Naldi, et al. · Journal of Clinical Oncology · 980

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

2019 · Michael T. Parsons, Emma Tudini, et al. · Human Mutation · 145

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

2007 · Antonino Musolino, Maria A. Bella, et al. · The Breast · 134

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

2017 · Silvia La Monica, Daniele Cretella, et al. · Journal of Experimental & Clinical Cancer Research · 83

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation

2016 · Silvia La Monica, Denise Madeddu, et al. · Journal of Thoracic Oncology · 76

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

2013 · on behalf of Bio-FAST trial group, M Tiseo, et al. · British Journal of Cancer · 73

Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype

2005 · A. Ruzzo, F. Graziano, et al. · Annals of Oncology · 71

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

2002 · C. Bozzetti, R. Nizzoli, et al. · Annals of Oncology · 61

Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas

2000 · Rita Nizzoli, Cecilia Bozzetti, et al. · Cancer · 52

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non‐small cell lung cancer patients

2015 · Cecilia Bozzetti, Rita Nizzoli, et al. · Diagnostic Cytopathology · 46

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

2003 · Cecilia Bozzetti, Nicola Personeni, et al. · Cancer · 44

Immunocytochemical evaluation of HER‐2/neu on fine‐needle aspirates from primary breast carcinomas

2003 · Rita Nizzoli, Cecilia Bozzetti, et al. · Diagnostic Cytopathology · 41

Estrogen and progesterone receptors in human meningiomas: Biochemical and immunocytochemical evaluation

1995 · Cecilia Bozzetti, Roberta Camisa, et al. · Surgical Neurology · 34

Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma

1994 · Cecilia Bozzetti, Rita Nizzoli, et al. · Breast Cancer Research and Treatment · 31

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

2019 · Anna Maria Militello, Teresa Zielli, et al. · Frontiers in Oncology · 30

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

2018 · Sarah M. Nielsen, Diana M. Eccles, et al. · JCO Precision Oncology · 29

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

2016 · A Musolino, N Naldi, et al. · The Pharmacogenomics Journal · 29

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

2005 · Antonino Musolino, Nadia Naldi, et al. · Breast Cancer Research and Treatment · 29

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

2021 · B. Pellegrino, L. Cavanna, et al. · ESMO Open · 26

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy

2013 · F V Negri, A Musolino, et al. · The Pharmacogenomics Journal · 25

Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples

2012 · Cecilia Bozzetti, Francesca V. Negri, et al. · Diagnostic Cytopathology · 25

Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.

1995 · R Nizzoli, C Bozzetti, et al. · PubMed · 23

Interobserver Reproducibility of Immunohistochemical Her-2/Neu Evaluation in Human Breast Cancer: The Real-World Experience

2004 · Italian Network for Quality Assurance of Tumor Biomarkers (INQAT) Group, A. Paradiso, et al. · The International Journal of Biological Markers · 22

HER-2/neu Evaluation by Fluorescence in Situ Hybridization on Destained Cytologic Smears from Primary and Metastatic Breast Cancer

2005 · Rita Nizzoli, Annamaria Guazzi, et al. · Acta Cytologica · 19

Comparison between ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma

1997 · Cecilia Bozzetti, Rita Nizzoli, et al. · Cancer · 19

Works count: 66

Citation count: 2,360

H-index: 22

I10-index: 37